Rivastigmine in the treatment of Alzheimer's disease
| dc.contributor.author | de Silva, H.A. | en_US |
| dc.contributor.author | Gunatilake, S.B. | en_US |
| dc.creator.corporateauthor | Department of Pharmacology, University of Colombo | en_US |
| dc.creator.corporateauthor | State Pharmaceuticals Corporation | en_US |
| dc.date.accessioned | 2014-10-29T09:19:28Z | |
| dc.date.available | 2014-10-29T09:19:28Z | |
| dc.date.issued | 2002 | en_US |
| dc.description.abstract | No Abstract Available | |
| dc.identifier.citation | The Sri Lanka Prescriber. 2002; 10(1/2): pp.5-6 | en_US |
| dc.identifier.department | Pharmacology | en_US |
| dc.identifier.department | Medicine | en_US |
| dc.identifier.issn | 1391-0736(Print) | en_US |
| dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/1502 | |
| dc.publisher | State Pharmaceuticals Corporation | en_US |
| dc.subject | Alzheimer Disease | en_US |
| dc.title | Rivastigmine in the treatment of Alzheimer's disease | en_US |
| dc.type | Report | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: